Anterix Inc.ATEXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank25
5Y CAGR-52.6%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-52.6%/yr
Long-term compound
Percentile
P25
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.67% |
| 2024 | 28.34% |
| 2023 | 23.55% |
| 2022 | -17.27% |
| 2021 | 47.07% |
| 2020 | 27.78% |
| 2019 | -1.74% |
| 2018 | 1.55% |
| 2017 | 75.12% |
| 2016 | 32.14% |